NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $431,886 | +10.7% | 4,240 | 0.0% | 0.31% | +9.9% |
Q2 2023 | $390,080 | 0.0% | 4,240 | 0.0% | 0.28% | 0.0% |
Q1 2023 | $390,080 | +4.0% | 4,240 | +2.5% | 0.28% | 0.0% |
Q4 2022 | $375,218 | +19.5% | 4,136 | 0.0% | 0.28% | +14.1% |
Q3 2022 | $314,000 | -10.3% | 4,136 | 0.0% | 0.25% | -3.1% |
Q2 2022 | $350,000 | -3.6% | 4,136 | 0.0% | 0.26% | +13.3% |
Q1 2022 | $363,000 | +0.3% | 4,136 | 0.0% | 0.23% | +3.7% |
Q4 2021 | $362,000 | +7.1% | 4,136 | 0.0% | 0.22% | -2.2% |
Q3 2021 | $338,000 | +0.6% | 4,136 | +12.2% | 0.22% | -3.5% |
Q2 2021 | $336,000 | +6.7% | 3,686 | 0.0% | 0.23% | -1.7% |
Q1 2021 | $315,000 | -9.5% | 3,686 | 0.0% | 0.24% | -19.0% |
Q4 2020 | $348,000 | +8.4% | 3,686 | 0.0% | 0.29% | -4.9% |
Q3 2020 | $321,000 | -0.6% | 3,686 | -0.2% | 0.30% | -10.3% |
Q2 2020 | $323,000 | +5.9% | 3,694 | 0.0% | 0.34% | -8.1% |
Q1 2020 | $305,000 | -15.7% | 3,694 | -3.5% | 0.37% | +7.2% |
Q4 2019 | $362,000 | – | 3,826 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |